FAK is a pathway critical for the growth and survival of cancer stem cells and the study marks the launch of Verastem's development efforts in Japan.
http://eon.businesswire.com/news/eon/20130924005195/en/Verastem-Initiates-Trial-Defactinib-Japan
http://eon.businesswire.com/news/eon/20130924005195/en/Verastem-Initiates-Trial-Defactinib-Japan
No comments:
Post a Comment